NCT05161195 2026-04-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
Clinical Trials
12 trialsNCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
NCT01673984 2025-05-23
GREAT
Ipsen
Phase 4 Terminated
NCT03971110 2022-12-16
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
AstraZeneca
Phase 4 Terminated
NCT04248621 2021-07-29
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
Wonju Severance Christian Hospital
Phase 4 Unknown
NCT01738724 2020-08-13
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
University of Sao Paulo
Phase 4 Terminated
NCT03591549 2018-07-23
Fulvestrant in Metastatic Breast Cancer
Assiut University
Phase 4 Unknown
NCT02749825 2016-04-25
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Pharmatech
Phase 4 Terminated
NCT00746031 2010-10-25
Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids
University of Edinburgh
Phase 4 Completed
NCT00255268 2007-08-28
CMAB vs IMAB in Metastatic Prostate Cancer
AstraZeneca
Phase 4 Withdrawn
NCT00293696 2007-05-08
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Tampere University
Phase 4 Completed
NCT00293670 2006-02-17
FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
Tampere University
Phase 4 Unknown